High-affinity monomeric 67-kD laminin receptors and prognosis in pancreatic endocrine tumours

Journal of Pathology

Volumn 183, Issue 1, 1997, Pages 62-69

  Pelosi, Giuseppe ^a   Pasini, Felice ^b   Bresaola, Enrica ^b   Bogina, Giuseppe ^b   Pederzoli, Paolo ^b   Biolo, Sonia ^a   Menard, Sylvie ^c   Zamboni, Giuseppe ^b  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

67 kD laminin receptor; Endocrine tumours; Metastases; Pancreas; Prognosis; Survival

Indexed keywords

CELL SURFACE RECEPTOR; KI 67 ANTIGEN; LAMININ; LAMININ RECEPTOR;

ADULT; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CELL SURFACE; ENDOCRINE TUMOR; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PANCREAS TUMOR; PRIORITY JOURNAL; PROGNOSIS;

FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; PROGNOSIS; RECEPTORS, LAMININ; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0030874057     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199709)183:1<62::AID-PATH1095>3.0.CO;2-A     Document Type: Article

References (40)

1. Aznavoorian S, Murphy AN, Stetler-Stevenson WG, Liotta LA. Molecular aspects of tumor cell invasion and metastasis. Cancer 1993: 71: 1368-1383.
2. Hunt G. The role of laminin in cancer invasion and metastasis. Exp Cell Biol 1989; 57: 165-176.
3. Liotta LA. Tumor invasion and metastases. Role of the extracellular matrix: Rhoads Memorial Award Lecture. Cancer Res 1986; 46: 1-7.
4. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64: 327-336.
5. Charonis AS, Tsilibary EC, Yurchenco PD, Furthmayr H, Coritz A. Binding of laminin to type IV collagen: a morphological study. J Cell Biol 1985; 100: 1848-1853.
6. Chung AE, Freeman IL, Braginski JE. A novel extracellular membrane elaborated by a mouse embryonal carcinoma-derived cell line. Biochem Biophys Res Commun 1977; 79: 859-868.
7. Engvall E. Laminin variants: why, where and when? Kidney Int 1993; 43: 2-6.
8. Laurie GW, Horikoshi S, Killen PD, Segui-Real B, Yamada Y. In situ hybridization reveals temporal and spatial changes in cellular expression of mRNA for a laminin receptor, laminin, and basement membrane (type IV) collagen in the developing kidney. J Cell Bioll 1989; 109: 1351-1362.
9. Timpl R, Rhode H, Gehron Robey Y, Rennard SI, Foidart JM, Martin GR. A glycoprotein from basement membranes. J Biol Chem 1979; 254: 9933-9937.
10. Hynes RO. Integrins: versatility, modulation, and signalling in cell adhesion. Cell 1992; 69: 11-25.
11. Hinek A, Rabinovitch M, Keeley F, Okamura-Oho Y, Callahan J. The 67-kD elastin/laminin-binding protein is related to an enzymatically inactive, alternatively spliced form of b-galactosidase. J Clin Invest 1993; 91: 1198-1205.
12. Castronovo V, Taraboletti G, Sobel ME. Functional domains of the 67-kDa laminin receptor precursor. J Biol Chem 1991; 266: 20440-20446.
13. Martignone S, Pellegrini R, Villa E, et al. Characterization of two monoclonal antibodies directed against the 67 kDa high affinity laminin receptor and application for the study of breast carcinoma progression. Clin Fxp Metastasis 1992; 10: 379-386.
14. Pellegrini R, Martignone S, Ménard S, Colnaghi MI. Laminin receptor expression and function in small-cell lung carcinoma. Int J Cancer 1994; 8(Suppl): 116-120.
15. Cioce V, Margulies IM, Sobel ME, Castronovo V. Interaction between the 67 kilodalton metastasis-associated laminin receptor and laminin. Kidney Int 1993; 43: 30-37.
16. Graf J, Iwamoto Y, Sasaki M, et al. Identification of an amino acid sequence in laminin mediating cell attachment, chemolaxis, and receptor binding. Cell 1987; 48: 989-996.
17. Castronovo V, Taraboletti G, Liotta LA. Modulation of laminin receptor expression by estrogen and progestins in human breast cancer lines. J Natl Cancer Inst 1989; 81: 781-788.
18. Stallmach A, Rosewicz S, Kaiser A, Matthes H, Schuppan D, Riecken EO. Laminin binding in membranes of a rat pancreatic acinar cell line are targets for glucocorticoids. Gastroenterology 1992; 102: 237-247.
19. Taraboletti G, Belotti D, Giavazzi R, Sobel ME, Castronovo V. Enhancement of metastatic potential of murine and human melanoma cells by laminin receptor peptide G: attachment of cancer cells to subendothelial matrix as a pathway for hemotogenous metastasis. J Natl Cancer Inst 1993; 85: 235-240.
20. Wewer UM, Taraboletti G, Sobel ME, Albrechtsen R, Liotta LA. Role of laminin receptor in tumor cell migration. Cancer Res 1987; 47: 5691-5698.
21. Castronovo V, Colin C, Claysmith AP, et al. Immunodetection of the metastasis associated laminin receptor in human breast cancer cells obtained by fine-needle aspiration biopsy. Am J Pathol 1990; 137: 1373-1381.
22. Daidone MG, Silvestrini R, D'Errico A, et al. Laminin receptors, collagenase IV and prognosis in node-negative breast cancers. Int J Cancer 1991; 48: 529-532.
23. Marques LA, Franco ELF, Torloni H, Brentani M, da Silva-Neto JB. Brentani RR. Independent prognostic Value of laminin receptor expression in breast cancer survival. Cancer Res 1990; 50: 1479-1483.
24. Martignone S, Menard S, Bufalino R, et al. Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. J Natl Cancer Inst 1993; 85: 398-402.
25. Sanjuan X, Fernandez PL, Miquel R, et al. Overexpression of the 67-kD laminin receptor correlates with tumour progression in human colorectal carcinoma. J Pathol 1996; 179: 376-380.
26. Campo E, Monteagudo C, Castronovo V, Claysmith AP, Fernandez PL, Sobel ME. Detection of laminin receptor mRNA in human cancer cell lines and colorectal tissues by in situ hybridization. Am J Pathol 1992; 141: 1073-1083.
27. Cioce V, Castronovo V, Shmookler B, et. al. Increased expression of the laminin receptor in human colon cancer. J Natl Cancer Inst 1991; 83: 29-36.
28. Vacca A, Ribatti D, Roncali L, et al. Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor. Cancer 1993; 72: 455-461.
29. Alanen KA, Joensuu H, Klemi PJ, Marin S, Alavaikko M, Nevalainen TJ. DNA ploidy in pancreatic neuroendocrine tumors. Am J Clin Pathol 1990; 93: 784-788.
30. Klöppel G, Heitz PU. Pancreatic endocrine tumors. Pathol Res Pract 1988; 183: 155-168.
31. Venkatesh S, Ordonez NG, Ajani J, et al. Islet cell carcinoma of the pancreas: a study of 98 patients. Cancer 1990; 65: 354-357.
32. Pelosi G, Bresaola E, Bogina G, et al. Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy. A comparative study with PCNA and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables. Hum Pathol 1996; 27: 1124-1134.
33. Gerdes J, Li L. Schlueter C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991; 138: 867-873.
34. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc J 1958; 53: 457-481.
35. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
36. Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187-202.
37. von Herbay A, Sieg B, Schürmann G, Hofmann WJ, Betzler M, Otto HF. Proliferative activity of neuroendocrine tumors of the gastroentero-pancreatic endocrine system: DNA flow cytometric and immunohistological investigations. Gut 1991; 32: 949-953.
38. Pelosi G, Zamboni G, Doglioni C, et al. Immunodetection of proliferating cell nuclear antigen assesses the growth fraction and predicts malignancy in endocrine tumors of the pancreas. Am J Surg Pathol 1992; 16: 1215-1225.
39. Viale G, Doglioni C, Gambacorta M, Zamboni G, Coggi G, Bordi C. Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin. Cancer 1992; 70: 2268-2277.
40. Capella C, Heitz PU, Höfler H, Solcia E, Klöppel G. Revised classification of neuroendocrine tumors of the lung, pancreas and gut. Virchows Arch 1995; 425: 547-560.